Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.11
+0.27 (3.05%)
Apr 8, 2026, 3:42 PM EDT - Market open

Bioventus Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
758499690333162863
Market Cap Growth
18.66%-27.70%107.09%105.83%-81.23%-
Enterprise Value
1,028771.26994.83710.98603.791,233
Last Close Price
9.117.4410.505.272.6114.49
PE Ratio
26.7922.55-18.75-2.12-1.01-96.60
Forward PE
11.759.7920.0021.8217.1721.50
PEG Ratio
1.07----2.07
PS Ratio
1.350.881.200.650.322.00
PB Ratio
3.222.714.671.920.501.88
P/TBV Ratio
859.322.794.581.900.491.44
P/FCF Ratio
10.666.9218.2741.77-10.7991.11
P/OCF Ratio
10.296.6917.8021.73-11.9737.53
EV/Sales Ratio
1.811.361.741.391.182.86
EV/EBITDA Ratio
13.257.6428.95-29.19-5.4026.28
EV/EBIT Ratio
18.2514.29-65.47-8.70-3.61102.27
EV/FCF Ratio
14.2610.7026.3389.07-40.21130.23
Debt / Equity Ratio
1.221.221.661.660.930.64
Debt / EBITDA Ratio
2.912.919.77-16.21-3.747.62
Debt / FCF Ratio
4.084.088.8849.47-27.8437.77
Net Debt / Equity Ratio
1.321.321.992.061.190.68
Net Debt / EBITDA Ratio
2.402.408.56-14.69-3.476.69
Net Debt / FCF Ratio
3.373.377.7844.84-25.8333.13
Asset Turnover
0.800.800.750.470.390.50
Inventory Turnover
--4.052.092.472.82
Quick Ratio
1.121.120.800.910.550.93
Current Ratio
1.701.701.311.530.901.45
Return on Equity (ROE)
13.17%26.35%-46.27%-100.05%-75.70%6.21%
Return on Assets (ROA)
8.11%8.11%-1.78%-7.49%-9.85%1.69%
Return on Invested Capital (ROIC)
11.25%11.25%-2.36%-8.96%-11.55%2.20%
Return on Capital Employed (ROCE)
10.37%10.37%-2.64%-9.59%-15.82%1.70%
Earnings Yield
2.96%4.44%-5.33%-47.25%-99.23%-1.04%
FCF Yield
9.39%14.45%5.47%2.39%-9.27%1.10%
Buyback Yield / Dilution
-6.77%-6.77%-3.03%-2.05%-35.00%11.70%
Total Shareholder Return
-6.77%-6.77%-3.03%-2.05%-35.00%11.70%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q